日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity

三嗪酮衍生物通过干扰逆转录酶活性抑制HIV-1复制

Urano, Emiko; Miyauchi, Kosuke; Kojima, Yoko; Hamatake, Makiko; Ablan, Sherimay D; Fudo, Satoshi; Freed, Eric O; Hoshino, Tyuji; Komano, Jun

Peptide HIV-1 integrase inhibitors from HIV-1 gene products

来自 HIV-1 基因产物的肽类 HIV-1 整合酶抑制剂

Suzuki, Shintaro; Urano, Emiko; Hashimoto, Chie; Tsutsumi, Hiroshi; Nakahara, Toru; Tanaka, Tomohiro; Nakanishi, Yuta; Maddali, Kasthuraiah; Han, Yan; Hamatake, Makiko; Miyauchi, Kosuke; Pommier, Yves; Beutler, John A; Sugiura, Wataru; Fuji, Hideyoshi; Hoshino, Tyuji; Itotani, Kyoko; Nomura, Wataru; Narumi, Tetsuo; Yamamoto, Naoki; Komano, Jun A; Tamamura, Hirokazu

Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome

EBNA1的显性负性衍生物在Epstein-Barr病毒感染的急性期抑制EBNA1介导的转化基因表达,且该抑制作用独立于病毒基因组的快速丢失。

Kariya, Yumi; Hamatake, Makiko; Urano, Emiko; Yoshiyama, Hironori; Shimizu, Norio; Komano, Jun

The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.

新型 CXCR4 拮抗剂 KRH-3955 是一种口服生物利用度高且对人类免疫缺陷病毒 1 型感染具有极强抑制作用的抑制剂:与 AMD3100 的比较研究

Murakami Tsutomu, Kumakura Sei, Yamazaki Toru, Tanaka Reiko, Hamatake Makiko, Okuma Kazu, Huang Wei, Toma Jonathan, Komano Jun, Yanaka Mikiro, Tanaka Yuetsu, Yamamoto Naoki

Separate elements are required for ligand-dependent and -independent internalization of metastatic potentiator CXCR4

转移增强因子CXCR4的配体依赖性和非配体依赖性内化需要不同的要素。

Futahashi, Yuko; Komano, Jun; Urano, Emiko; Aoki, Toru; Hamatake, Makiko; Miyauchi, Kosuke; Yoshida, Takeshi; Koyanagi, Yoshio; Matsuda, Zene; Yamamoto, Naoki